PMHNP Practice Authority in Arkansas: Independence, Physician Agreements and Schedule II

AANP's May 2026 map classes Arkansas as reduced, meaning a collaborative practice agreement with a physician is the default condition of prescribing.

That label is AANP's advocacy classification, and it omits the pathway Arkansas actually runs: a Full Independent Practice Authority certificate issued through the Full Independent Practice Credentialing Committee.

A nurse practitioner who qualifies no longer needs the agreement, and the certificate displayed in the office must say so.

For a PMHNP moving to Arkansas, the practical sequence is agreement first, certificate once the requirements are met.

The hours threshold is exactly six thousand two hundred forty (6,240), earned in either route the qualification names: under a board-required agreement with a physician, or in another state, territory, or foreign country that authorizes certified nurse practitioners to practice with prescriptive authority, with proof of licensure in good standing.

Hours are not the whole test — the same subsection also requires a current Arkansas CNP/CNS licence, no encumbrance on any nursing licence in any jurisdiction, and an active prescriptive authority certificate.

In Arkansas the only in-state route is the physician agreement; the rule sets no nurse-practitioner-mentorship route.

The wording differs inside the rule: the qualification accepts any state, territory or foreign country authorizing prescriptive practice, while the applicant affidavit in (c)(2)(B) reads "Prescribing in a full practice authority state" — an applicant bringing hours from a reduced-practice state should confirm with the Board.

The application goes to the Full Independent Practice Credentialing Committee; the certificate is renewed every three (3) years.

If it lapses, the nurse practitioner may practise under a collaborative practice agreement until it is renewed.

Until the certificate issues, prescribing runs inside a collaborative practice agreement with a physician.

Prescribing happens as established in written protocols; a legend drug, medicine or therapeutic device outside them needs a specific written or verbal order from a physician or podiatrist obtained before the prescription is issued, with the consultation documented in the patient's record.

If the agreement ends, the APRN notifies the board in writing within seven (7) days, and prescriptive authority cannot be reactivated until a new agreement is on file.

Ratio caps, chart-review quotas and proximity rules were not located in the sections read.

The certificate of prescriptive authority covers drugs in Schedules II through V, plus hydrocodone combination products; Schedule I is barred.

Schedule II splits into two different rules.

Opioids: except hydrocodone combination products, no prescription for more than a five-day period, with referral to a physician if more are needed for pain.

Stimulants: a PMHNP may prescribe a Schedule II stimulant only once a physician originated it, evaluated the patient within six (6) months, and the condition is the same — so an Arkansas PMHNP cannot initiate one for a new ADHD diagnosis.

The APRN may substitute a therapeutically equivalent medication and must notify the originating physician of the substitution.

Section 123-702(b)(2) makes full-independent-practice holders follow the same provisions.

Prescribers also owe opioid-antagonist co-prescriptions in the rule's trigger cases, file their DEA registration number with the board, and cannot prescribe Schedule II for themselves or immediate family.

A separate state controlled-substance registration was not located in the sources read.

A PMHNP registers with the DEA as a mid-level practitioner, and that registration only covers what Arkansas lets the nurse practitioner prescribe.

A DEA form listing Schedules II to V does not suspend the five-day opioid cap or the stimulant criteria.

The same holds in telehealth: the DEA and HHS telemedicine flexibilities, extended through December 31, 2026, allow registered practitioners to prescribe controlled medications remotely without an in-person evaluation, but they lift no state limit — an Arkansas stimulant continuation prescribed by video still needs the physician initiation and the six-month physician evaluation.

Arkansas has not enacted the APRN Compact.

The compact takes effect only once seven states enact it, and as of September 2026 five had (Delaware, North Dakota, South Dakota, Utah and Wyoming), so no nurse practitioner holds a multistate APRN licence today.

The Nurse Licensure Compact is an RN compact and gives no nurse practitioner authority across state lines.

A PMHNP practising in Arkansas needs an Arkansas APRN licence from the Board of Nursing, plus the prescriptive certificate.

The prescribing-privileges rule carries the newest amendment in the documents read: its history line records rule amendment 2026-77, effective July 4, 2026.

The Full Practice Authority subpart itself was adopted May 15, 2022 and amended November 15, 2024.

Arkansas's move to the Code of Arkansas Rules codification became official January 1, 2025, which is why the citations here read 17 CAR rather than an older register number.

The enabling statute, reported as Act 412 of 2021 and codified in the Arkansas Code at section 17-87-314, was not read, and the act number is unverified — confirm it with the Board before relying on it.